CatalystWireBeta

UK small-cap RNS · 22 Sep 2026

Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.

Sort: Newest · Largest companies
  1. 22:11
    Results of the Previously Announced Solicitation of Consents to Proposed Amendments to the Indenture Governing its Senior Secured Amortizing Notes due 2031 Results
    Noteholders holding at least 50% consented to the amendments, clearing a creditor condition for the Colombia and Ecuador sale to Maurel & Prom. The amendments only take effect when the sale closes.
    Moved: Sale of Colombia and Ecuador: Definitive agreement signed; approvals pending → Noteholder consents obtained; other conditions pending · October 2026 notes amortization: Notes assumed or redeemed at completion → 2031 Notes consent obtained
  2. 16:25
    Director/PDMR Shareholding Director dealing
  3. 14:53
    Tender Offer - Maximum Acceptance Amount
    (incorporated in England under the Building Societies Act 1986)
    Capital return +0.0% on the day
  4. 13:53
    Half-year Results Results
    Half Year Report for the Six Months Ended 30 June 2026
    Dilutive fundraise −1.3% on the day
  5. 12:57
    Director/PDMR Shareholding Director dealing
  6. 12:02
    Holding(s) in Company Holding
  7. 12:00
    Consent Solicitation – Important Update
    A new OFAC designation of VTB Bank blocks a noteholder and stops the Issuer relying on its licence, so the SUN consent solicitation cannot complete until an amended licence arrives. This delays the route to repaying noteholders.
    Moved: Delayed SSN and SUN coupon payment: SUN consent solicitation launched 8 Sep 2026 → Consent solicitation held up by OFAC licence · Sale of Kazakhstan operations: SPA signed; SUN consent solicitation launched → SPA signed; SUN approval condition delayed by OFAC
  8. 07:50
    Director/PDMR Shareholding Director dealing
    Forterra plc (the "Company") was notified on 17th of September 2026 that on the same day Gavin Hill, Non-Executive Director, purchased 28,944 Ordinary Shares in the Company at a price of £1.383.
    Insider conviction +1.2% on the day
  9. 07:15
    Operational and Commercial Update
    Sets a Q4 2026 target for a propped fracture at Sagebrush-1 after IPT found acid treatments may have been limited by the rock, so commercial flow is still unproven. Cash also goes to a related-party investment.
    Project milestones £0.2m · 3% of mcapoutlook positive3 signals in 3 months – usually about 2 −4.7% on the day
    Moved: Sagebrush-1 extended flow test: EPT complete; engineering assessment nearing completion → Stimulation design and execution planning underway · Coyote Wash development: IMDA approved; placing funds permitting and planning → Permitting and planning; 2027 drilling planned
  10. 07:01
    WRAP Retail Offer Fundraise
    WRAP Retail Offer for up to £0.525 million
    Dilutive fundraise −40.9% on the day
  11. 07:00
    Chair Succession Board change
    Chair David Morgan steps down on 31 December 2026 and CEO John Carey becomes Executive Chair from January 2027. This is continuity, but it combines the Chair and CEO roles in one person.
    Turnaround plan with targets first in 1 year +9.8% on the day
    Moved: Turnaround plan: Simplification complete; H2 delivery pending → Simplification done; leadership transition set for January 2027
  12. 07:00
    Updated Company Presentation
    KEFI Gold and Copper (AIM: KEFI), the exploration and development company focused on gold and copper projects in the Federal Democratic Republic of Ethiopia and the Kingdom of Saudi Arabia, is pleased to advise that an updated Company presentation has been …
    Project milestones outlook mixed −0.3% on the day
    Moved: Tulu Kapi project financing and construction: Suspended; stakeholder support reaffirmed; no resumption date → Suspended; development plan and schedule under review
  13. 07:00
    Placing and Subscription Fundraise
    Placing and Subscription to raise £5.25 million (before expenses)
    Dilutive fundraise 3% of mcapfirst in 11 months −40.9% on the day
  14. 07:00
    Fundraising, Capital Access Window & Trading Halt Fundraise
    Following the adoption of its revised investing strategy in 2025 focused on identifying and investing in high-growth physical AI and robotics companies at an early stage of commercialisation, SEED has completed three investments.
    Dilutive fundraise +0.0% on the day
  15. 07:00
    Special Dividend – GBP/USD Exchange Rate
    Asiamet Resources Limited (AIM: ARS) refers to the Company announcement dated 9 September 2026 regarding the payment of a special cash dividend (the "Special Dividend") to be distributed to shareholders in Great British Pounds (GBP).
    Capital return −6.1% on the day
  16. 07:00
    Directorate Change Board change
    The finance director leaves the Board on 25 September 2026 after a serious injury, one day before interim results and midway through the transformation plan, so there is some disruption risk.
    New CEO / reset outlook positive −1.0% on the day
    Moved: Transformation plan: Operational objectives in progress; leadership complete → Leadership change: interim CFO replaces departing CFO
  17. 07:00
    Half-year Results Results
    The company only reiterates guidance given after its August update. That guidance (£180–200m revenue, mid-single-digit margin) is well below the March £220–240m and c.10% margin, so it is not an upgrade.
    Upgrade / downgrade cycle outlook mixed, loweredfirst in 1 year +6.0% on the day
    Moved: new: Durham site ramp-up – GMP online, first run done; ramp expected H2 · new: FY26 guidance trend – Guidance at lower level, reiterated at H1
  18. 07:00
    Half-year Results Results
    Portfolio milestones landed and runway to end-2028 holds, but PureTech-level cash fell from $277.0m to $220.0m in the half and operating expenses rose to $55.9m.
    Project milestones outlook positive −7.3% on the day
    Moved: LYT-200 AML development: EOP1 done; Fast Track; Phase 2 design set → Fast Track and Phase 2 design set; funding sought · Deupirfenidone IPF Phase 3: Phase 3 under way; first patient dosed → Phase 3 dosing; Celea financed · Seaport Therapeutics IPO: Priced upsized at $18.00; trading from 1 May → IPO closed in May 2026; stake valued (closed)
  19. 07:00
    Half-year Results Results
    Interim results match what the 3 August trading update flagged: revenue down 10% and EBITDA down 16%. FY26 revenue and EBITDA guidance is only confirmed, after May's lower-end steer.
    Turnaround plan with targets in lineoutlook mixedfirst in 12 months −3.0% on the day
    Moved: OEM customer order weakness: OEM ARR down to £13.7m; still weak → OEM ARR down 18%; FY26 revenue lower · Delayed UK customer projects: Still delayed by component shortages → Non-recurring revenue timing risk persists · Accelerated FY26 investment programme: Progressing to plan; margin 13.2% → Progressing; H1 margin 13.2%
  20. 07:00
    FY26 Q3 Trading Update Trading update
    FY26 PBT guidance rises to at least £12m from c.£10m, but the company says the gain mainly reflects one-off working capital benefits that will not recur, so it is not a better run-rate.
    Upgrade / downgrade cycle ahead of expectationsoutlook positive, raisedfirst in 9 months +0.2% on the day
    Moved: FY26 profit before tax of about £10m (guidance cut from earlier expectations).: on_track → changed – FY26 PBT guidance is lifted to at least £12m from c.£10m, mainly on one-off working capital benefits that will not recur. · Further share buyback: Under way; £8.8m bought by 20 July → Under way; £10.5m bought by 21 September · Offer for the company: Possible offer rejected by Board; PUSU pending → Possible offer rejected; PUSU pending
  21. 07:00
    Half-year Results Results
    H1 swings to a £6.3m pre-tax loss (HY25 profit £9.8m) on weak plot sales; net debt rises to £132.9m and no interim dividend, though H2-weighted FY consensus is reiterated.
    New CEO / reset outlook mixedfirst in 6 months +1.4% on the day
    Moved: 2026 earnings reset: H1 update: plot sales guided materially lower → H1 loss; FY in line with £9.7m consensus · CEO succession: Successor named; HBD MD now filled → Hutchinson CEO; review under way · Golden Valley development, Cheltenham: Phase one forward funded; construction under way → Phase one under construction, fully funded
  22. 07:00
    Final Results Results
    FY26 revenue fell 17% to £4.63m and adjusted EBITDA to £0.66m from £1.96m, as the Bridgestone royalty rate cut and missed growth targets bit. Figures match the June downgrade, so little surprise, but cash improved to £1.50m.
    Upgrade / downgrade cycle below expectationsoutlook mixedfirst in 12 months −6.9% on the day
    Moved: Translogik customer ramp-up: Continental development contract won; 6-month build → Continental development under way; FY27 upturn expected · SAWsense pilot production line: Procurement complete; initial validation as expected → Pilot line operational at Weston on the Green
  23. 07:00
    Half-year Results Results
    H1 LFL net revenue fell 1.4% on a soft Q1, but Q2 returned to modest growth, better than FY25's 7.3% fall. LFL operating profit still dropped about 32%.
    New CEO / reset in lineoutlook mixed −8.2% on the day
    Moved: Share buyback programme: Ongoing buyback programme → Initial programme completed; extension under evaluation · FY25 guidance and FY26 recovery: Four months in line; FY26 growth targeted → H1 weak, Q2 growth; FY in line · CEO succession and interim leadership: Rabbatts Executive Chair; no CEO named → Rabbatts stays Executive Chair; no CEO
  24. 07:00
    Result of Placing Fundraise
    Placing completed at the 1.0p price, a 13% discount to the prior close, issuing 100m shares (about 12% of the enlarged capital). Proceeds go mainly to buying crypto reserve assets, one month after the company said equity would not be needed for overheads. Heavy oversubscription and CEO participation soften it.
    Balance-sheet stress / refinancing £1.0m · 13% of mcap +0.0% on the day
    Moved: Digital Asset Income Strategy: First equity raise under strategy launched → Placing completed; admission pending · Cash and cost pressure: Equity raised, but mostly for reserve → Placing completed; cash still thin
  25. 07:00
    Trading Statement Trading update
    Interim CEO Parsonage becomes permanent CEO after stabilising the business during the forensic investigation, ending leadership uncertainty. Chair Levett is also made permanent.
    New CEO / reset outlook mixed −16.7% on the day
    Moved: Board and management changes: Interim CFO in; NED talks advanced → CEO and Chair made permanent; NED imminent · CEO succession and conduct investigation: Findings published; finance team being rebuilt → Permanent leadership in place; remediation continues
  26. 07:00
    Half-year Results Results
    H1 headline operating profit rose 15% to £2.5m, a little above the £2.4m in July's trading update, after January's warning. Full-year targets are held, but they rely on a heavily H2-weighted profit.
    Turnaround plan with targets in lineoutlook positivefirst in 12 months +9.8% on the day
    Moved: Debt reduction and dividend restart: Net bank debt up to £11.0m; dividend still paused → Net bank debt £11.0m; H2 reduction expected · new: Turnaround plan – Simplification complete; H2 delivery pending
  27. 07:00
    Half-year Results Results
    Aeorema Communications plc / Index: AIM / Epic: AEO / Sector: Media
    Upgrade / downgrade cycle ahead of expectations3 guidance upgrades in 3 months – usually less than 1 +2.7% on the day
  28. 07:00
    Half-year Results Results
    The Board only says it is confident of delivering its 2026 expectations. No new figure is given, and the 107% is visibility against consensus, so this is not an upgrade.
    Upgrade / downgrade cycle in lineoutlook positive4 business updates in 3 months – usually about 1 +9.4% on the day
    Moved: FY 2026 revenue growth guidance: On track; H1 +22% cc, 91% visibility → On track; visibility 107% of consensus at 31 August · new: Relay customer contract wins – New customers in final contract negotiations
  29. 07:00
    2026 Interim Results Results
    Strong momentum delivering 14.5% increase in Adjusted Operating Profit mainly driven by our Energy Transition performance 2026 Adjusted Operating Profit expected to be ahead of market expectations
    Upgrade / downgrade cycle ahead of expectationsfirst in 6 months −5.5% on the day
  30. 07:00
    Half-year Results Results
    Interim results confirm that the Board expects full-year profit in line with its expectations, as stated at the July pre-close update. Guidance is unchanged, not raised.
    Upgrade / downgrade cycle in lineoutlook mixedfirst since Oct 2023 +2.9% on the day
    Moved: EMEA and North America recovery: North America growing; EMEA down on Middle East, Germany → North America +8.4%; EMESEA down on Middle East, Germany · Digital and AI strategy: Exploring AI solutions for productivity → Upgraded ecommerce sites and AI-driven solutions delivered · Middle East conflict impact: Trading below last year; H2 exposure uncertain → Profitable but on significantly lower volumes
  31. 07:00
    Half-year Results Results
    The £0.99m pre-tax profit is a gain from recognising BCM's 50% of Mbe, not operations. Cash fell to £1.48m from £2.50m while the resource grew to 1.66Moz.
    Project milestones outlook positive −8.2% on the day
    Moved: Mbe resource delineation and development: Updated MB01-S MRE published; planning next work → Resource at 1.66Moz; further work planned · BCM earn-in to 50% interests: JV agreement drafting in progress → Now 50:50 JVs; agreements still being finalised · Bibemi Exploitation Licence application: Amended technical report submitted; decision awaited in 2026 → Licence negotiation under way; conclusion expected in coming months
  32. 07:00
    Nine Month Trading Update Trading update
    Full year trading anticipated to be slightly ahead of expectations with Drache progressing well and the acquisition of GV Filtri completed
    Upgrade / downgrade cycle ahead of expectations +2.0% on the day
  33. 07:00
    Trading Update Trading update
    Portfolio growth continues with three new investments, one disposal, a larger Pantheon stake and more enquiries. Group funds fell as cash was deployed, but the Board says resources are sufficient.
    Capital return outlook mixedfirst in 7 months −1.2% on the day
    Moved: Deploying cash into new investments: Continuing; Autonomy investment agreed 25 June 2026 → Continuing; Group funds £37.4m at 31 July 2026
  34. 07:00
    Final Results Results
    Final Results for the year ended 30 June 2026 (the “Year”)
    Upgrade / downgrade cycle ahead of expectationsfirst in 6 months +12.3% on the day

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note